ACW Results of Annual General Meeting 25/11/19 download Created with Sketch. 196.92KB Share ACW Managing Director's AGM Presentation 25/11/19 download Created with Sketch. 2.43MB Share ACW ACW 2019 AGM Chairman's Address 25/11/19 download Created with Sketch. 166.6KB Share ACW Response to ASX Price Query 20/11/19 PRICE SENSITIVE download Created with Sketch. 272.08KB Share ACW R&D Tax Incentive rebate received of $4.58 million 24/10/19 PRICE SENSITIVE download Created with Sketch. 140.48KB Share ACW September 2019 Quarterly Update 24/10/19 PRICE SENSITIVE download Created with Sketch. 302.11KB Share ACW Annual Report to shareholders 22/10/19 download Created with Sketch. 1.79MB Share ACW Notice of Annual General Meeting/Proxy Form 22/10/19 download Created with Sketch. 794.26KB Share ACW Cognitive improvement demonstrated with Xanamem 01/10/19 PRICE SENSITIVE download Created with Sketch. 2.63MB Share ACW Actinogen Medical Conference Call 30/09/19 download Created with Sketch. 132.63KB Share ACW Notification of 2019 Annual General Meeting Date 27/09/19 download Created with Sketch. 130.78KB Share ACW Trading Halt 27/09/19 PRICE SENSITIVE download Created with Sketch. 232.45KB Share ACW Appendix 4G 16/08/19 download Created with Sketch. 101.3KB Share ACW Appendix 4E & Annual Report 16/08/19 PRICE SENSITIVE download Created with Sketch. 1.79MB Share ACW June 2019 Quarterly Update 30/07/19 PRICE SENSITIVE download Created with Sketch. 237.23KB Share ACW Clinical Development and Scientific Conference Update 03/07/19 download Created with Sketch. 141.45KB Share ACW Xanamen Clinical Development & Investor Update 26/06/19 PRICE SENSITIVE download Created with Sketch. 2.47MB Share ACW Actingoen Medical participating in the BIO 2019 Convention 03/06/19 download Created with Sketch. 142.86KB Share ACW XanaHES Trial to Continue 29/05/19 PRICE SENSITIVE download Created with Sketch. 142.12KB Share ACW Ceasing to be a substantial holder 10/05/19 download Created with Sketch. 181.92KB Share ACW Ceasing to be a substantial holder from AEF 08/05/19 download Created with Sketch. 430.49KB Share ACW Phase II Alzheimer's Disease Trial - results 07/05/19 PRICE SENSITIVE download Created with Sketch. 145.16KB Share ACW Trading Halt 03/05/19 PRICE SENSITIVE download Created with Sketch. 234.39KB Share ACW Actinogen Updated Investor Presentation 01/05/19 download Created with Sketch. 3.53MB Share ACW March 2019 Quarterly Update 24/04/19 PRICE SENSITIVE download Created with Sketch. 295.74KB Share ACW Change in substantial holding 23/04/19 download Created with Sketch. 200.93KB Share ACW Lapse of Options 15/04/19 download Created with Sketch. 133.07KB Share ACW Appendix 3Y-Mr Malcolm McComas 12/04/19 download Created with Sketch. 25.82KB Share ACW Appendix 3B 12/04/19 download Created with Sketch. 156.69KB Share ACW New Clinical Development Opportunities for Xanamem 10/04/19 PRICE SENSITIVE download Created with Sketch. 141.79KB Share ACW Cleansing Notice 04/04/19 download Created with Sketch. 100.42KB Share ACW Appendix 3B 04/04/19 download Created with Sketch. 153.44KB Share ACW Appendix 3X-Malcolm McComas 04/04/19 download Created with Sketch. 66.89KB Share ACW Actinogen Medical appoints new Non-Executive Director 04/04/19 download Created with Sketch. 134.24KB Share ACW DSMB again reaffirms XanADu trial to continue without change 26/03/19 PRICE SENSITIVE download Created with Sketch. 135.23KB Share ACW Change in substantial holding (Replacement Form 604) 22/03/19 download Created with Sketch. 274.83KB Share ACW Change in substantial holding 22/03/19 download Created with Sketch. 244.57KB Share ACW Actinogen Updated Investor Presentation 21/03/19 download Created with Sketch. 2.88MB Share ACW Appendix 3B 19/03/19 download Created with Sketch. 159.03KB Share ACW Becoming a substantial holder 14/03/19 download Created with Sketch. 304.67KB Share ACW Amended-Notification of Expiry of Listed Options 04/03/19 download Created with Sketch. 205.14KB Share ACW Notification of Expiry of Listed Options 27/02/19 download Created with Sketch. 154.77KB Share ACW Appendix 4D & Half-Year Financial Statements 22/02/19 PRICE SENSITIVE download Created with Sketch. 671.9KB Share ACW 1st participant dosed in important new Xanamem study-XanaHES 11/02/19 PRICE SENSITIVE download Created with Sketch. 137.29KB Share ACW Appendix 3B 04/02/19 download Created with Sketch. 153.92KB Share ACW December 2018 Quarterly Update 29/01/19 PRICE SENSITIVE download Created with Sketch. 237.64KB Share ACW ACW Presents at SACHS Neuroscience Forum during JPM Week 07/01/19 download Created with Sketch. 2.79MB Share ACW Appendix 3Y-Dr George Morstyn 13/12/18 download Created with Sketch. 26.42KB Share ACW Appendix 3Y-Dr Bill Ketelbey 13/12/18 download Created with Sketch. 26.34KB Share ACW Appendix 3y-Dr Geoff Brooke 13/12/18 download Created with Sketch. 26.62KB Share ACW Appendix 3B 13/12/18 download Created with Sketch. 155.42KB Share ACW Cleansing Notice 30/11/18 download Created with Sketch. 99.75KB Share ACW Appendix 3B-Exercise of Options 30/11/18 download Created with Sketch. 159.29KB Share ACW Appendix 3Z-Dr Jason Loveridge 28/11/18 download Created with Sketch. 26.74KB Share ACW Retirement of Dr Jason Loveridge as a Non-Executive Director 28/11/18 download Created with Sketch. 131.66KB Share ACW Results of Annual General Meeting 28/11/18 download Created with Sketch. 189.04KB Share ACW Managing Director's AGM Presentation 28/11/18 download Created with Sketch. 1.17MB Share ACW Chairman's AGM Address 28/11/18 download Created with Sketch. 89.83KB Share ACW Final patient enrolled in landmark Alzheimer's trial-XanADu 26/11/18 PRICE SENSITIVE download Created with Sketch. 132.3KB Share ACW Actinogen updated investor presentation 26/11/18 download Created with Sketch. 2.82MB Share ACW Cleansing Notice 14/11/18 download Created with Sketch. 99.78KB Share ACW Appendix 3B-Exercise of Options 14/11/18 download Created with Sketch. 159.68KB Share ACW Supportive research highlights cortisol hypothesis 08/11/18 download Created with Sketch. 179.93KB Share ACW September 2018 Quarterly Update 31/10/18 PRICE SENSITIVE download Created with Sketch. 238.76KB Share ACW Vesting Conditions Met 31/10/18 download Created with Sketch. 130.33KB Share ACW Actinogen to be showcased at AusBiotech Invest 2018 30/10/18 download Created with Sketch. 694.34KB Share ACW Enrolment target achieved for major Alzheimer's trial-XanADu 29/10/18 download Created with Sketch. 132.73KB Share ACW XanADu trial to be presented at global Alzheimer conference 24/10/18 download Created with Sketch. 138.03KB Share ACW Annual Report to Shareholders 23/10/18 download Created with Sketch. 1.56MB Share ACW Notice of Annual General Meeting/Proxy Form 23/10/18 download Created with Sketch. 463.61KB Share ACW Recruitment to close for important Alzheimer's trial-XanADu 22/10/18 PRICE SENSITIVE download Created with Sketch. 134.26KB Share ACW Actinogen to be showcased at key conferences 17/10/18 download Created with Sketch. 1.24MB Share ACW Becoming a substantial holder from AEF 16/10/18 download Created with Sketch. 440.95KB Share ACW R&D Tax Rebate Received Totalling $3.15 Million 10/10/18 PRICE SENSITIVE download Created with Sketch. 138.04KB Share ACW Notification of 2018 Annual General Meeting Date 28/09/18 download Created with Sketch. 127.19KB Share ACW Cleansing Notice 18/09/18 download Created with Sketch. 99.77KB Share ACW Appendix 3B-Exercise of Options 18/09/18 download Created with Sketch. 160.45KB Share ACW Actinogen to Present to Investors in Singapore & Sydney 11/09/18 download Created with Sketch. 1.56MB Share ACW Appendix 4G 29/08/18 download Created with Sketch. 109.87KB Share ACW Appendix 4E & Financial Statements 29/08/18 PRICE SENSITIVE download Created with Sketch. 1.56MB Share ACW DSMB reaffirms that XanADu continue without change 22/08/18 PRICE SENSITIVE download Created with Sketch. 133.21KB Share ACW XanADu Patient Enrolment Advancing Towards Completion 15/08/18 PRICE SENSITIVE download Created with Sketch. 159.37KB Share ACW Updated Xanamem Clinical Development Program 30/07/18 PRICE SENSITIVE download Created with Sketch. 135.28KB Share ACW June 2018 Quarterly Report 25/07/18 PRICE SENSITIVE download Created with Sketch. 266.02KB Share ACW Cleansing Notice 24/07/18 download Created with Sketch. 99.9KB Share ACW Appendix 3B 24/07/18 download Created with Sketch. 161.32KB Share ACW Ceasing to be a substantial holder 24/07/18 download Created with Sketch. 50.78KB Share ACW Placement under Share Purchase Plan Shortfall 17/07/18 PRICE SENSITIVE download Created with Sketch. 137.83KB Share ACW Appendix 3Y-Dr Bill Ketelbey 16/07/18 download Created with Sketch. 25.53KB Share ACW Appendix 3Y-Dr Geoff Brooke 16/07/18 download Created with Sketch. 25.63KB Share ACW Appendix 3B-Share Purchase Plan 13/07/18 download Created with Sketch. 160.56KB Share ACW Share Purchase Plan Completed 12/07/18 download Created with Sketch. 151.87KB Share ACW Cleansing Notice 12/07/18 download Created with Sketch. 98.75KB Share ACW Appendix 3B 12/07/18 download Created with Sketch. 160.58KB Share ACW New Study Sites Added to Accelarate Patient Recruitment 06/07/18 PRICE SENSITIVE download Created with Sketch. 130.82KB Share ACW Cleansing Notice 05/07/18 download Created with Sketch. 98.64KB Share ACW Appendix 3B - Exercise of Options 05/07/18 download Created with Sketch. 160.28KB Share ACW Results of Meeting 05/07/18 download Created with Sketch. 185.09KB Share ACW Change of Address 19/06/18 download Created with Sketch. 123.84KB Share ACW Share Purchase Plan 06/06/18 PRICE SENSITIVE download Created with Sketch. 258.09KB Share
